• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用离散事件模拟估计结直肠异时癌自然史的未知参数。

Estimating the unknown parameters of the natural history of metachronous colorectal cancer using discrete-event simulation.

机构信息

Department of Industrial and Systems Engineering, University of Wisconsin–Madison, Madison, Wisconsin (Department of Management Sciences, University of Waterloo Waterloo (FSE, OA)

Formerly at Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. Current affiliation is Analysis Group, Inc., Boston, Massachusetts (RB)

出版信息

Med Decis Making. 2011 Jul-Aug;31(4):611-24. doi: 10.1177/0272989X10391809. Epub 2011 Jan 6.

DOI:10.1177/0272989X10391809
PMID:21212440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3117014/
Abstract

OBJECTIVES

Some aspects of the natural history of metachronous colorectal cancer (MCRC), such as the rate of progression from adenomatous polyp to MCRC, are unknown. The objective of this study is to estimate a set of parameters revealing some of these unknown characteristics of MCRC.

METHODS

The authors developed a computer simulation model that mimics the progression of MCRC for a 5-year period following the treatment of primary colorectal cancer (CRC). They obtained the inputs of the simulation model using longitudinal data for 284 CRC patients from the Mayo Clinic, Rochester.

RESULTS

Five-year MCRC incidence and all-cause mortality were 7.4% and 12.7% in the patient cohort, respectively. Statistical analysis showed that 5-year MCRC incidence was associated with gender (P = 0.05), whereas both all-cause and CRC-related mortalities were associated with age (P < 0.001 and P = 0.01). Estimated annual probabilities of progression from adenomatous polyp to MCRC and from MCRC to metastatic MCRC were 0.14 and 0.28, respectively. Annual probabilities of mortality after MCRC and metastatic MCRC treatments were estimated to be 0.06 and 0.26, respectively. The estimated annual probability of mortality due to undetected MCRC was 0.16.

CONCLUSIONS

The results imply that MCRC, especially in women, may be more common than suggested by previous studies. In addition, statistics derived from the clinical data and results of the simulation model indicate that gender and age affect the progression of MCRC.

摘要

目的

一些结直肠多发癌(MCRC)的自然史特征尚不明确,如腺瘤性息肉进展为 MCRC 的速度。本研究旨在估计一组参数,以揭示 MCRC 的一些未知特征。

方法

作者开发了一个计算机模拟模型,模拟了原发性结直肠癌(CRC)治疗后 5 年内 MCRC 的进展情况。他们使用来自梅奥诊所罗切斯特院区的 284 例 CRC 患者的纵向数据为模拟模型输入。

结果

患者队列的 5 年 MCRC 发病率和全因死亡率分别为 7.4%和 12.7%。统计分析显示,5 年 MCRC 发病率与性别有关(P=0.05),而全因死亡率和 CRC 相关死亡率均与年龄有关(P<0.001 和 P=0.01)。估计的从腺瘤性息肉进展为 MCRC 和从 MCRC 进展为转移性 MCRC 的 5 年进展概率分别为 0.14 和 0.28。MCRC 和转移性 MCRC 治疗后死亡的年概率估计分别为 0.06 和 0.26。未检测到的 MCRC 导致的年死亡率估计为 0.16。

结论

结果表明,MCRC,特别是女性中的 MCRC,可能比之前的研究更为常见。此外,从临床数据和模拟模型的结果得出的统计学数据表明,性别和年龄影响 MCRC 的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e6/3117014/3bd09ac89a24/nihms274823f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e6/3117014/e07d1e8796cf/nihms274823f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e6/3117014/3bd09ac89a24/nihms274823f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e6/3117014/e07d1e8796cf/nihms274823f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17e6/3117014/3bd09ac89a24/nihms274823f2.jpg

相似文献

1
Estimating the unknown parameters of the natural history of metachronous colorectal cancer using discrete-event simulation.使用离散事件模拟估计结直肠异时癌自然史的未知参数。
Med Decis Making. 2011 Jul-Aug;31(4):611-24. doi: 10.1177/0272989X10391809. Epub 2011 Jan 6.
2
The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer.表皮生长因子受体(EGFR)表达及KRAS突变在同时性或异时性转移性结直肠癌患者中的预后价值
BMC Cancer. 2013 Dec 13;13:599. doi: 10.1186/1471-2407-13-599.
3
Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.错配修复缺陷转移性结直肠癌的结局:梅奥诊所的经验。
Oncologist. 2018 Sep;23(9):1083-1091. doi: 10.1634/theoncologist.2017-0289. Epub 2018 Apr 19.
4
Risk factors for metachronous colorectal cancer in Lynch syndrome patients: a registry-based observational mono-institutional study cohort.林奇综合征患者异时性结直肠癌的危险因素:基于登记的观察性单机构研究队列。
Int J Clin Oncol. 2020 Sep;25(9):1644-1652. doi: 10.1007/s10147-020-01700-2. Epub 2020 May 19.
5
Practice Patterns and Survival Outcomes of Immunotherapy for Metastatic Colorectal Cancer.转移性结直肠癌免疫治疗的实践模式与生存结果
JAMA Netw Open. 2025 Mar 3;8(3):e251186. doi: 10.1001/jamanetworkopen.2025.1186.
6
Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database.同步转移性结直肠癌原发肿瘤切除的预后价值:来自 ARCAD 数据库的一线随机试验的个体患者数据分析。
Eur J Cancer. 2018 Mar;91:99-106. doi: 10.1016/j.ejca.2017.12.014. Epub 2018 Jan 30.
7
Cost-effectiveness of alternative colonoscopy surveillance strategies to mitigate metachronous colorectal cancer incidence.减轻异时性结直肠癌发病率的替代结肠镜监测策略的成本效益
Cancer. 2016 Aug 15;122(16):2560-70. doi: 10.1002/cncr.30091. Epub 2016 Jun 1.
8
Impact of Metastasectomy in the Multimodality Approach for V600E Metastatic Colorectal Cancer: The Mayo Clinic Experience.V600E 转移性结直肠癌多模式治疗中转移灶切除术的影响:梅奥诊所的经验。
Oncologist. 2018 Jan;23(1):128-134. doi: 10.1634/theoncologist.2017-0230. Epub 2017 Sep 13.
9
Risk of metachronous colorectal cancer following colectomy in Lynch syndrome: a systematic review and meta-analysis.林奇综合征患者结肠切除术后异时性结直肠癌的风险:一项系统评价和荟萃分析
Colorectal Dis. 2017 Jun;19(6):528-536. doi: 10.1111/codi.13679.
10
Association of Primary Tumor Site With Mortality in Patients Receiving Bevacizumab and Cetuximab for Metastatic Colorectal Cancer.贝伐珠单抗联合西妥昔单抗治疗转移性结直肠癌患者的原发肿瘤部位与死亡率的关系。
JAMA Surg. 2018 Jan 1;153(1):60-67. doi: 10.1001/jamasurg.2017.3466.

引用本文的文献

1
Beware of counter-intuitive levels of false discoveries in datasets with strong intra-correlations.在具有强内部相关性的数据集中,要警惕虚假发现的反直觉水平。
Genome Biol. 2025 Aug 18;26(1):249. doi: 10.1186/s13059-025-03734-z.
2
A Scoping Review on Calibration Methods for Cancer Simulation Models.癌症模拟模型校准方法的范围综述
Med Decis Making. 2025 Aug 11:272989X251353211. doi: 10.1177/0272989X251353211.
3
A two-phase approach to re-calibrating expensive computer simulation for sex-specific colorectal neoplasia development modeling.

本文引用的文献

1
An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard.生命价值的经验性估计:更新肾透析的成本效益标准。
Value Health. 2009 Jan-Feb;12(1):80-7. doi: 10.1111/j.1524-4733.2008.00401.x.
2
Calibration methods used in cancer simulation models and suggested reporting guidelines.癌症模拟模型中使用的校准方法及建议的报告指南。
Pharmacoeconomics. 2009;27(7):533-45. doi: 10.2165/11314830-000000000-00000.
3
What is the most cost-effective strategy to screen for second primary colorectal cancers in male cancer survivors in Korea?
一种两阶段方法,用于重新校准昂贵的计算机模拟,以进行性别特异性结直肠肿瘤发展建模。
BMC Med Inform Decis Mak. 2022 Sep 18;22(1):244. doi: 10.1186/s12911-022-01991-7.
4
Synchronous Neoplastic Lesions In Referred Patients With Colorectal Cancer: A Retrospective Cohort Study.转诊的结直肠癌患者中的同步性肿瘤病变:一项回顾性队列研究。
Cancer Manag Res. 2019 Nov 26;11:9951-9959. doi: 10.2147/CMAR.S229376. eCollection 2019.
5
Multiobjective Calibration of Disease Simulation Models Using Gaussian Processes.基于高斯过程的疾病仿真模型的多目标校准
Med Decis Making. 2019 Jul;39(5):540-552. doi: 10.1177/0272989X19862560. Epub 2019 Aug 2.
6
Nonidentifiability in Model Calibration and Implications for Medical Decision Making.模型校准中的不可识别性及其对医疗决策的影响。
Med Decis Making. 2018 Oct;38(7):810-821. doi: 10.1177/0272989X18792283.
7
Cost-effectiveness of alternative colonoscopy surveillance strategies to mitigate metachronous colorectal cancer incidence.减轻异时性结直肠癌发病率的替代结肠镜监测策略的成本效益
Cancer. 2016 Aug 15;122(16):2560-70. doi: 10.1002/cncr.30091. Epub 2016 Jun 1.
8
Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study.原发性结直肠癌后异时性结直肠癌的危险因素:一项前瞻性队列研究。
Int J Cancer. 2016 Sep 1;139(5):1081-90. doi: 10.1002/ijc.30153. Epub 2016 May 9.
9
Using Active Learning for Speeding up Calibration in Simulation Models.利用主动学习加速仿真模型中的校准
Med Decis Making. 2016 Jul;36(5):581-93. doi: 10.1177/0272989X15611359. Epub 2015 Oct 15.
10
Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review.结直肠癌监测的益处是否超过其副作用?一项系统评价。
World J Gastrointest Oncol. 2014 May 15;6(5):104-11. doi: 10.4251/wjgo.v6.i5.104.
在韩国男性癌症幸存者中筛查继发性原发性结直肠癌的最具成本效益的策略是什么?
World J Gastroenterol. 2009 Jul 7;15(25):3153-60. doi: 10.3748/wjg.15.3153.
4
Cancer statistics, 2009.2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
5
Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.评估结直肠癌筛查的检测策略:美国预防服务工作组的决策分析
Ann Intern Med. 2008 Nov 4;149(9):659-69. doi: 10.7326/0003-4819-149-9-200811040-00244. Epub 2008 Oct 6.
6
Computed tomographic colonography to screen for colorectal cancer, extracolonic cancer, and aortic aneurysm: model simulation with cost-effectiveness analysis.计算机断层结肠成像筛查结直肠癌、结外癌和主动脉瘤:成本效益分析的模型模拟
Arch Intern Med. 2008 Apr 14;168(7):696-705. doi: 10.1001/archinte.168.7.696.
7
United States life tables, 2004.美国生命表,2004年。
Natl Vital Stat Rep. 2007 Dec 28;56(9):1-39.
8
The lifelong risk of metachronous colorectal cancer justifies long-term colonoscopic follow-up.异时性结直肠癌的终身风险证明了长期结肠镜随访的合理性。
Eur J Cancer. 2008 Mar;44(4):522-7. doi: 10.1016/j.ejca.2008.01.007. Epub 2008 Feb 5.
9
Age, sex and the risk of grade-specific second primary colorectal cancer: evidence for the protective effect of female hormone.年龄、性别与特定分级的结直肠癌第二原发癌风险:女性激素保护作用的证据
Eur J Cancer. 2007 Aug;43(12):1856-61. doi: 10.1016/j.ejca.2007.05.015. Epub 2007 Jul 2.
10
Detection of metachronous neoplasms in colorectal cancer patients: identification of risk factors.结直肠癌患者异时性肿瘤的检测:危险因素的识别
Dis Colon Rectum. 2007 Jul;50(7):971-80. doi: 10.1007/s10350-007-0237-2.